Scarica l'app Stockscreener
7.74
4.33%
-0.35
Dopo l'orario di chiusura:
7.77
0.03
+0.39%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Briacell Therapeutics Corp Borsa (BCTX) Ultime notizie
Why BriaCell Therapeutics Corp. Equity Warrant stock is favored by pension fundsProtective Put Strategies & Big Profit Low Trading - bollywoodhelpline.com
(BCT) Trading Signals (BCT:CA) - Stock Traders Daily
Form FWP BriaCell Therapeutics Filed by: BriaCell Therapeutics Corp. - StreetInsider
Profit Review: Why BriaCell Therapeutics Corp. stock remains undervaluedJuly 2025 Sector Moves & Expert-Curated Trade Recommendations - Улправда
Why hedge funds are buying BriaCell Therapeutics Corp. Equity Warrant stockMarket Activity Report & Risk Controlled Daily Plans - Улправда
Market Recap: How BriaCell Therapeutics Corp. Equity Warrant stock reacts to Fed rate cutsWeekly Stock Summary & Safe Entry Point Alerts - Улправда
Is BriaCell Therapeutics Corp. Equity Warrant stock oversold or undervaluedChart Signals & Fast Moving Trade Plans - Улправда
How BriaCell Therapeutics Corp. Equity Warrant stock reacts to Fed rate cutsCPI Data & Verified Momentum Stock Alerts - Улправда
Is BriaCell Therapeutics Corp. stock a buy for dividend growth2025 Sector Review & Reliable Breakout Forecasts - Улправда
Is BriaCell Therapeutics Corp. Equity Warrant stock recession proof2025 Year in Review & Technical Pattern Based Signals - Улправда
Will BriaCell Therapeutics Corp. stock gain from strong economyBuy Signal & Daily Stock Trend Reports - DonanımHaber
Is BriaCell Therapeutics Corp. stock a safe haven assetMarket Sentiment Summary & Technical Pattern Based Signals - DonanımHaber
Why BriaCell Therapeutics Corp. stock could benefit from AI revolutionJuly 2025 Opening Moves & Smart Investment Allocation Tips - DonanımHaber
BriaCell’s phase 3 breast cancer trial named a 2026 ‘clinical trial to watch’ by Nature Medicine - MSN
Why BriaCell Therapeutics Corp. stock remains undervalued2025 Growth vs Value & High Win Rate Trade Tips - Улправда
BriaCell’s Phase 3 Breast Cancer Trial Named a 2026 ‘Clinical Trial to Watch’ by Nature Medicine - TipRanks
"Eleven clinical trials that will shape medicine in 2026"BriaCell Phase 3 Trial Featured in Nature Medicine - Investing News Network
Briacell phase 3 trial featured in Nature Medicine - marketscreener.com
'Eleven clinical trials that will shape medicine in 2026”BriaCell Phase 3 Trial Featured in Nature Medicine - The Manila Times
Briacell Phase 3 Trial Featured In Nature Medicine - TradingView — Track All Markets
“Eleven clinical trials that will shape medicine in 2026” – BriaCell Phase 3 Trial Featured in Nature Medicine - GlobeNewswire
Why one metastatic breast cancer trial is a key one to watch in 2026 - Stock Titan
BriaCell Therapeutics : Fact Sheet (20251216 Fact Sheet) - marketscreener.com
BriaCell Therapeutics : Investor Presentation (20251216 Website Presentation) - marketscreener.com
How to Take Advantage of moves in (BCT) (BCT:CA) - news.stocktradersdaily.com
Why Institutions Believe Bondada Engineering Limited Is Undervalued TodayMarket Liquidity Analysis & Build Wealth With Zero-Cost Tools - earlytimes.in
Rally Mode: What insider trading reveals about BriaCell Therapeutics Corp stockIPO Watch & Comprehensive Market Scan Insights - moha.gov.vn
(BCT) Trading Performance and Risk Management (BCT:CA) - news.stocktradersdaily.com
Top 3 Earnings Acceleration Buys for November - MSN
BriaCellModel Bria-IMT and Bria-OTSDestroy Cancer Cells - Environmental XPRT
BriaCell Therapeutics Corp. Reports Earnings Results for the First Quarter Ended October 31, 2025 - marketscreener.com
BriaCell (NASDAQ: BCTX) boosts R&D as going concern risk emerges - Stock Titan
BriaCell’s Bria-IMT shows promising results in metastatic breast cancer trials - MSN
BriaCell Therapeutics Corp Warrant 2021-26.02.26 on BriaCell Therapeutics - TradingView — Track All Markets
Net income of BriaCell Therapeutics Corp Warrant 2021-26.02.26 on BriaCell Therapeutics – NASDAQ:BCTXW - TradingView — Track All Markets
BriaCell reports positive data for breast cancer immunotherapy By Investing.com - Investing.com Nigeria
BriaCell (BCTX) Highlights Promising Data at 2025 SABCS Symposiu - GuruFocus
BriaCell’s Bria-IMT Shows Promising Results in Metastatic Breast Cancer Trials - TipRanks
BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025 - Investing News Network
BriaCell reports positive data for breast cancer immunotherapy - Investing.com
BriaCell (BCTX) Progresses with Phase 3 Study in Metastatic Brea - GuruFocus
BriaCell’s Phase 3 Study on Track for 2026 Data Readout - TipRanks
BriaCell's Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout - Investing News Network
BriaCell’s Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout - The Manila Times
Briacell's phase 3 patient enrollment on track for 1H2026 topline data readout - marketscreener.com
BriaCell's Phase 3 Patient Enrollment On Track For 1H2026 Topline Data Readout - TradingView — Track All Markets
Movement Recap: Will BriaCell Therapeutics Corp Equity Warrant stock outperform Dow Jones indexJuly 2025 Sector Moves & Expert-Curated Trade Recommendations - moha.gov.vn
BriaCell Therapeutics (BCTXZ) Stock Analysis Report | Financials & Insights - Benzinga
BriaCell Unveils Promising Clinical Data at 2025 SABCS - MSN
BriaCell Therapeutics : Investor Presentation (1Dec2025 Investor Presentation) - marketscreener.com
Will BriaCell Therapeutics Corp. Equity Warrant stock outperform Dow Jones indexQuarterly Profit Report & Long-Term Investment Growth Plans - Newser
BriaCell to present positive breast cancer therapy data at SABCS By Investing.com - Investing.com Australia
BriaCell Therapeutics (BCTXW) Stock Analysis Report | Financials & Insights - Benzinga
0.08%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):